These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 20531245)

  • 1. Role of ulinastatin in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis: the Emperor's New Clothes or Aladdin's Magic Lamp?
    Chen S; Shi H; Zou X; Luo H
    Pancreas; 2010 Nov; 39(8):1231-7. PubMed ID: 20531245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ulinastatin shows preventive effect on post-endoscopic retrograde cholangiopancreatography pancreatitis in a multicenter prospective randomized study.
    Fujishiro H; Adachi K; Imaoka T; Hashimoto T; Kohge N; Moriyama N; Suetsugu H; Kawashima K; Komazawa Y; Ishimura N; Ishihara S; Amano Y; Kinoshita Y
    J Gastroenterol Hepatol; 2006 Jun; 21(6):1065-9. PubMed ID: 16724996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventive effects of ulinastatin on post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients: a prospective, randomized, placebo-controlled trial.
    Yoo JW; Ryu JK; Lee SH; Woo SM; Park JK; Yoon WJ; Lee JK; Lee KH; Hwang JH; Kim YT; Yoon YB
    Pancreas; 2008 Nov; 37(4):366-70. PubMed ID: 18953247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventive effect of ulinastatin and gabexate mesylate on post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Zhang ZF; Yang N; Zhao G; Zhu L; Zhu Y; Wang LX
    Chin Med J (Engl); 2010 Sep; 123(18):2600-6. PubMed ID: 21034635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of somatostatin on prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis and hyperamylasemia: A systematic review and meta-analysis.
    Wang G; Xiao G; Xu L; Qiu P; Li T; Wang X; Wen P; Wen J; Xiao X
    Pancreatology; 2018 Jun; 18(4):370-378. PubMed ID: 29550097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiproteases in preventing post-ERCP acute pancreatitis.
    Tsujino T; Kawabe T; Omata M
    JOP; 2007 Jul; 8(4 Suppl):509-17. PubMed ID: 17625308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between ulinastatin and gabexate mesylate for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a prospective, randomized trial.
    Ueki T; Otani K; Kawamoto K; Shimizu A; Fujimura N; Sakaguchi S; Matsui T
    J Gastroenterol; 2007 Feb; 42(2):161-7. PubMed ID: 17351806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between ulinastatin and nafamostat for prevention of post-endoscopic retrograde cholangiopancreatography complications: a prospective, randomized trial.
    Park JY; Jeon TJ; Hwang MW; Sinn DH; Oh TH; Shin WC; Choi WC
    Pancreatology; 2014; 14(4):263-7. PubMed ID: 25062874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic corticosteroids do not prevent post-ERCP pancreatitis: a meta-analysis of randomized controlled trials.
    Bai Y; Gao J; Shi X; Zou D; Li Z
    Pancreatology; 2008; 8(4-5):504-9. PubMed ID: 18765955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of octreotide administration in the prophylaxis of post-ERCP pancreatitis and hyperamylasemia: A multicenter, placebo-controlled, randomized clinical trial.
    Li ZS; Pan X; Zhang WJ; Gong B; Zhi FC; Guo XG; Li PM; Fan ZN; Sun WS; Shen YZ; Ma SR; Xie WF; Chen MH; Li YQ
    Am J Gastroenterol; 2007 Jan; 102(1):46-51. PubMed ID: 17266687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic octreotide administration does not prevent post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials.
    Bai Y; Gao J; Zou DW; Li ZS
    Pancreas; 2008 Oct; 37(3):241-6. PubMed ID: 18815543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glyceryl trinitrate for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography: a meta-analysis of randomized, double-blind, placebo-controlled trials.
    Bai Y; Xu C; Yang X; Gao J; Zou DW; Li ZS
    Endoscopy; 2009 Aug; 41(8):690-5. PubMed ID: 19670137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic administration of somatostatin or gabexate does not prevent pancreatitis after ERCP: an updated meta-analysis.
    Andriulli A; Leandro G; Federici T; Ippolito A; Forlano R; Iacobellis A; Annese V
    Gastrointest Endosc; 2007 Apr; 65(4):624-32. PubMed ID: 17383459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic effect of somatostatin in preventing Post-ERCP pancreatitis: an updated meta-analysis.
    Qin X; Lei WS; Xing ZX; Shi F
    Saudi J Gastroenterol; 2015; 21(6):372-8. PubMed ID: 26655132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ulinastatin for pancreatitis after endoscopic retrograde cholangiopancreatography: a randomized, controlled trial.
    Tsujino T; Komatsu Y; Isayama H; Hirano K; Sasahira N; Yamamoto N; Toda N; Ito Y; Nakai Y; Tada M; Matsumura M; Yoshida H; Kawabe T; Shiratori Y; Omata M
    Clin Gastroenterol Hepatol; 2005 Apr; 3(4):376-83. PubMed ID: 15822043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prophylactic effect of somatostatin on post-therapeutic endoscopic retrograde cholangiopancreatography pancreatitis: a randomized, multicenter controlled trial.
    Lee KT; Lee DH; Yoo BM
    Pancreas; 2008 Nov; 37(4):445-8. PubMed ID: 18953260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatostatin and gabexate for post-endoscopic retrograde cholangiopancreatography pancreatitis prevention: meta-analysis of randomized placebo-controlled trials.
    Rudin D; Kiss A; Wetz RV; Sottile VM
    J Gastroenterol Hepatol; 2007 Jul; 22(7):977-83. PubMed ID: 17559376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gabexate in the prophylaxis of post-ERCP pancreatitis: a meta-analysis of randomized controlled trials.
    Zheng M; Chen Y; Yang X; Li J; Zhang Y; Zeng Q
    BMC Gastroenterol; 2007 Feb; 7():6. PubMed ID: 17295917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The results of the Tokyo trial of prevention of post-ERCP pancreatitis with risperidone (Tokyo P3R): a multicenter, randomized, phase II, non-placebo-controlled trial.
    Tsujino T; Isayama H; Nakai Y; Ito Y; Togawa O; Toda N; Arizumi T; Kogure H; Yamamoto K; Mizuno S; Yashima Y; Yagioka H; Sasaki T; Matsubara S; Yamamoto N; Hirano K; Sasahira N; Tada M; Koike K
    J Gastroenterol; 2013 Aug; 48(8):982-8. PubMed ID: 23090004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical trial of gabexate in the prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Xiong GS; Wu SM; Zhang XW; Ge ZZ
    Braz J Med Biol Res; 2006 Jan; 39(1):85-90. PubMed ID: 16400468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.